Global High-Priority Regulatory Events — July 13, 2026

13-07-2026

MTNL has disclosed a default in the payment of principal and interest to seven banks as of June 30, 2026, with total overdue principal of ₹7,794.34 crore and overdue interest of ₹1,700.99 crore. The company's total financial indebtedness stands at ₹37,223 crore, comprising bank loans of ₹9,495 crore, SG bonds of ₹24,071 crore, and a loan from DoT of ₹3,657 crore. This marks a continuation of the company's ongoing financial distress, with all loans classified as non-performing assets (NPAs) since 2024.

• · The earliest NPA date among the banks is August 12, 2024 (Union Bank of India), and the latest is February 3, 2025 (Indian Overseas Bank).
• · Union Bank of India has the highest overdue principal at ₹4,144.46 crore, followed by Indian Overseas Bank at ₹2,690.62 crore.
• · The company has been making similar default disclosures since at least July 2024, indicating a prolonged period of financial distress.

13-07-2026

Creative Newtech Ltd's Board approved the acquisition of 100% of Infinova (India) Private Limited for a budget of up to USD 4.00 Million. The deal includes Infinova's Indian operations, exclusive brand rights, technical assistance, its experienced team, and a Pune-based assembly and manufacturing facility. This acquisition supports Creative Newtech's strategic shift from a distribution-led model to an integrated surveillance technology platform, aligning with its Make in India initiative.

• · The acquisition is not a related-party transaction; promoters and group companies have no interest in Infinova India except in relation to the proposed transaction.
• · Infinova India was incorporated in 2010 and operates an assembly and manufacturing facility in Pune.
• · The final consideration is subject to due diligence, valuation reports, closing adjustments of working capital, and execution of definitive agreements.
• · The exact completion timeline will be disclosed upon execution of definitive agreements.
• · The consideration will be paid in cash.

13-07-2026

13-07-2026

Ansal Properties & Infrastructure Limited (APIL) has filed minutes of the 54th Committee of Creditors (CoC) meeting for its Fernhill Project in Gurugram, held on July 10, 2026. The meeting, chaired by Resolution Professional Jalesh Kumar Grover, was attended by the Authorized Representative of Home Buyers (100% voting rights) and an unsecured financial creditor. Key developments include an NCLT order dated July 2, 2026, directing M/s Samyak Projects Private Limited to cooperate with the RP and hand over project access and documents, but Samyak has not yet complied. Separately, the CIRP for APIL has been confined to Lucknow and Rajasthan projects per a January 7, 2026 NCLAT order, while the Fernhill Project remains under a separate CIRP.

• · The 54th CoC meeting was held virtually on July 10, 2026, with 100% voting rights present (Authorized Representative of Home Buyers and one unsecured financial creditor).
• · M/s Samyak Projects Private Limited has not complied with the NCLT order dated July 2, 2026, to hand over project access and documents within two weeks; the RP will issue reminders and take further action if non-compliance continues.
• · The CIRP for APIL has been confined to Lucknow and Rajasthan projects per NCLAT order dated January 7, 2026, while the Fernhill Project remains under a separate CIRP managed by Jalesh Kumar Grover.
• · The Serene Residency Group Housing Project in Greater Noida had its resolution plan approved by NCLT on October 6, 2025.
• · Most suspended directors of APIL were absent from the meeting, except Ashok Kumar Verma who attended via audio-visual mode.

13-07-2026

Somany Ceramics Limited's board approved three investment proposals totaling up to ₹75.80 crore: a ₹58.80 crore investment for up to 49% in Siravit Ceramics (a pre-revenue glazed vitrified tiles venture targeting the Southern market), a ₹2.00 crore investment for up to 50% in V.S. Industries (a newly incorporated Nepal-based construction chemicals JV), and a ₹15.00 crore additional investment in its subsidiary Sudha Somany Ceramics for plant modernization. While the subsidiary investment supports an existing profitable operation (FY26 turnover ₹24,306.87 lakh, up 5.5% YoY), the two new ventures are in pre-revenue entities with no historical turnover, carrying execution and market risks.

• · Siravit Ceramics has authorised share capital of ₹14,00,00,000 and paid-up capital of ₹8,60,00,000; it has not commenced commercial operations and turnover is nil.
• · V.S. Industries was incorporated on 27 April 2026 in Nepal with authorised capital of NPR 10,00,00,000 and paid-up capital of NPR 50,00,000; it has no turnover.
• · The Siravit Ceramics investment is a related party transaction under SEBI LODR, but the target is not a related party; promoters have no interest in it.
• · The V.S. Industries investment is not a related party transaction.
• · The SSCPL investment is a related party transaction (subsidiary) and will be at arm's length.
• · Completion timeline: Siravit Ceramics ~90 days; V.S. Industries ~120 days subject to regulatory approvals; SSCPL within statutory time limits.

13-07-2026

Lisata Therapeutics filed Amendment No. 2 to its Schedule 14D-9, extending the tender offer by Kuva Acquisition Corp. (a subsidiary of Kuva Labs Inc.) to July 16, 2026. As of July 10, 2026, approximately 5,105,552 shares (55.98% of outstanding) had been validly tendered, exceeding the minimum condition. The offer price is $4.00 per share in cash at closing plus up to $3.00 per share in contingent value rights (CVRs) tied to milestones.

• · The tender offer was extended from July 10, 2026 to July 16, 2026.
• · The depositary reported 5,105,552 shares tendered as of 12:45 p.m. on July 10, 2026.
• · The offer includes a contingent value right (CVR) with potential additional payments up to $3.00 per share.
• · Parent and Purchaser expect consummation promptly after the extended expiration, subject to remaining conditions.

13-07-2026

Bowen Acquisition Corp (BOWN) is being delisted from Nasdaq effective July 20, 2026, after a lengthy appeals process that ended with the Nasdaq Listing and Hearing Review Council upholding the initial delisting determination. The company failed to meet multiple listing standards, including Listing Rules 5450(b)(2)(B), 5450(a)(2), 5450(b)(2)(A), 5450(b)(2)(C), and 5101, and all appeals were exhausted by January 2026.

• · Delisting effective at the opening of trading on July 20, 2026.
• · Initial Staff determination notified on July 15, 2025.
• · Company appealed to the Listing Qualifications Hearings Panel on July 22, 2025; hearing held August 21, 2025; Panel decision issued September 4, 2025.
• · Company appealed Panel decision on September 18, 2025; Panel upheld decision and suspended securities on November 3, 2025.
• · NLHRC issued Final Action Letter on January 26, 2026, upholding the Panel decision; no further appeal was filed.
• · Staff determination became final on December 15, 2025 due to the NLHRC decision.

13-07-2026

Future Vision II Acquisition Corp. (FVNNR) issued a $191,475 unsecured promissory note to HWei Super Speed Co. Ltd. to fund a one-month extension of its deadline to complete a business combination, from July 13, 2026 to August 13, 2026. The note carries no interest and is convertible into units at $10.00 per unit upon a business combination, but is forgiven if no deal closes. This extension loan signals the SPAC is still pursuing a merger but has not yet consummated a business combination, and the note's conversion feature is capped at $1,500,000 aggregate.

• · The note is unsecured, bears no interest, and is payable upon consummation of a business combination.
• · Proceeds must be deposited into the trust account to extend the business combination deadline from July 13, 2026 to August 13, 2026.
• · The note can be converted into units at $10.00 per unit, identical to placement units from the IPO private placement.
• · Conversion is capped at an aggregate $1,500,000 across all similar working capital/extension loans from the Payee and affiliates.
• · If no business combination occurs by the extended deadline, the note is forgiven and the Payee has no right to payment.
• · The Payee waives any claim to the trust account distributions.
• · The note is governed by New York law and cannot be assigned without Maker's consent prior to a business combination.

13-07-2026

Emcure Pharmaceuticals has executed Share Transfer Agreements to acquire the remaining 12.05% stake in its subsidiary Gennova Biopharmaceuticals for an aggregate cash consideration of ₹2,318.7 Million, making Gennova a wholly-owned subsidiary. Gennova reported a turnover of ₹4,917.42 Million for FY26 with a PAT of only ₹54.25 Million, indicating thin profitability. The acquisition is expected to close by July 31, 2026.

• · Gennova's PAT for FY26 was only ₹54.25 Million on turnover of ₹4,917.42 Million, implying a net profit margin of ~1.1%.
• · The acquisition consideration of ₹2,318.7 Million for a 12.05% stake values 100% of Gennova at approximately ₹19,240 Million (₹2,318.7M / 12.05%).
• · Gennova's turnover growth slowed sharply from 14.4% in FY26 to just 1.9% in FY25, indicating near-flat performance in the prior year.
• · The transaction involves related parties as a Promoter/Director of Emcure is also a Director of Gennova, but is stated to be at arm's length.
• · Completion is expected on or before July 31, 2026.

13-07-2026

Mercantile Ventures Limited (Transferee) has received NCLT approval for the Scheme of Amalgamation with India Radiators Limited (Transferor), with an appointed date of January 1, 2025. Under the share exchange ratio, shareholders of India Radiators will receive 10 equity shares of Mercantile Ventures for every 36 shares held. The record date for determining eligible shareholders is July 24, 2026, and the scheme will become effective upon filing the NCLT order with the Registrar of Companies.

• · Face value of both companies' equity shares is INR 10 each fully paid up.
• · NCLT order was dated July 8, 2026, from Division Bench - I, Chennai.
• · Appointed date for the amalgamation is January 1, 2025.
• · The effective date will be communicated after filing the NCLT order with the Registrar of Companies, Chennai.

13-07-2026

India Radiators Ltd (Transferor Company) has received NCLT approval for its amalgamation with Mercantile Ventures Ltd (Transferee Company). The Board approved a share exchange ratio of 10 equity shares of the transferee for every 36 shares of the transferor, with a record date of July 24, 2026, and an appointed date of January 1, 2025. The scheme will become effective upon filing the NCLT order with the Registrar of Companies.

• · NCLT order dated July 8, 2026, sanctioned the amalgamation scheme.
• · Record date for determining shareholders entitled to transferee shares is July 24, 2026.
• · Appointed date for the amalgamation is January 1, 2025.
• · Effective date will be communicated after filing the NCLT order with the Registrar of Companies.

13-07-2026

Indo-National Limited has acquired an additional 1.18% equity stake in Medcuore Medical Solutions Private Ltd (MMSPL) for ₹74,90,808, increasing its aggregate shareholding to 60.34%. The acquisition is a cash transaction at ₹16,536 per share, aimed at facilitating business growth and revenue expansion. MMSPL, which manufactures air monitoring systems and air purifiers, reported a sharp increase in turnover to ₹1,45,60,000 in FY26 from ₹35,41,484 in FY25, though its FY24 turnover was ₹47,68,000, indicating a decline from FY24 to FY25 before the recent surge.

• · The acquisition is not a related party transaction; no promoter/promoter group/group companies have interest in MMSPL.
• · MMSPL was incorporated on June 7, 2020.
• · The indicative completion timeframe for the acquisition is up to FY 2027-28.
• · No governmental or regulatory approvals are required for the acquisition.
• · MMSPL's turnover declined from ₹47,68,000 in FY24 to ₹35,41,484 in FY25 before surging to ₹1,45,60,000 in FY26.

13-07-2026

RDB Real Estate Constructions Limited has approved a 49% investment in a new Special Purpose Vehicle (SPV) named ASHOKA - RDB INFRASTRUCTURE & DEVELOPMENT PRIVATE LIMITED, to be incorporated for developing a Gems & Jewellery Park under PPP mode in Raipur, Chhattisgarh. The investment is a cash consideration of ₹49,000 for 4,900 equity shares of ₹10 each. The filing does not provide any financial performance data or period-over-period comparisons, as it is a forward-looking incorporation announcement.

• · The SPV is being incorporated in India and belongs to the Real Estate industry.
• · Ashoka Buildcon Limited is the holding company of the incorporated entity, with no relation to the listed entity.
• · No governmental or regulatory approvals are required for the incorporation.
• · The consideration is in cash, not share swap.

13-07-2026

SEBI issued an adjudication order against Excel Technovation Pvt Ltd on July 13, 2026, in connection with illiquid stock options trading. The order imposes a penalty for violations related to the manipulation of illiquid stock options on the stock exchange.

• · The order was issued by SEBI's Adjudication Officer under the category 'Orders of AO Enforcement'.
• · The matter involves 'Illiquid Stock Options', indicating potential market manipulation or irregular trading practices.

13-07-2026

Tierra Agrotech Limited (TAL) has received an observation letter from BSE Limited regarding its composite scheme of arrangement with Nishpra Community Solutions Private Limited (NSPL). The scheme, approved by TAL's board in January 2026, is now one step closer to completion after BSE's review. No financial details or specific conditions of the observation letter were disclosed.

• · The scheme was initially approved by TAL's board on January 12, 2026.
• · The application to BSE was filed on January 13, 2026.
• · The observation letter was received on July 13, 2026.
• · The scheme is under Sections 230 to 232 of the Companies Act, 2013.

13-07-2026

Simbhaoli Sugars Limited, undergoing Corporate Insolvency Resolution Process (CIRP) since July 2024, has reported audited consolidated financial results for the quarter and year ended March 31, 2026, which received an adverse audit opinion. The auditor highlighted significant uncertainties, including a disclaimer of opinion on subsidiary Simbhaoli Power Private Limited (SPPL) due to net losses, going concern doubts, and disputes with joint venture partner SSL. Additionally, the Hon'ble NCLAT on July 13, 2026 dismissed an appeal by promoter Ms. Gursimran Kaur Mann and disposed of a farmer's appeal with directions, while the company remains under IRP management.

• · The Hon'ble NCLAT orally dismissed the appeal by promoter Ms. Gursimran Kaur Mann and disposed of the farmer's appeal with directions on July 13, 2026.
• · The auditor of SPPL issued a Disclaimer of Opinion due to multiple uncertainties including going concern, impairment, and disputes with JV partner SSL.
• · SPPL's net loss improved to ₹2138.80 Lakh from ₹2908.40 Lakh in the prior year, but current liabilities exceeded current assets by ₹16,308.30 Lakh (up from ₹15,681.20 Lakh).
• · One turbine at the Simbhaoli plant remained broken down throughout the year, and there was no power generation at the Chilwaria plant.
• · Subsidiary ICCPL received an Adverse Opinion due to disputed unbilled revenue of ₹492.42 Lakh and held-back earnest money deposits of ₹150.50 Lakh.

13-07-2026

Winsome Yarns Limited has informed the exchanges that a Monitoring Committee meeting will be held on July 16, 2026, to consider the reduction/cancellation of 95% of existing equity shares and the issuance of new equity shares to prospective allottees, as per the NCLT-approved resolution plan under the Insolvency and Bankruptcy Code. The trading window for designated persons will remain closed until 48 hours after the outcome of the meeting. The filing does not provide any financial performance data for the current or prior periods.

• · The meeting is of the Monitoring Committee, not the full Board.
• · The NCLT order approving the resolution plan was dated April 16, 2026.
• · The trading window closure applies to designated persons and their immediate relatives under the company's insider trading code.
• · The company's scrip code is 514348 and symbol is WINSOME.

13-07-2026

Reliance Home Finance Limited (RHFL), which is undergoing a Corporate Insolvency Resolution Process (CIRP) initiated in September 2025, has announced that the 12th meeting of the Committee of Creditors (CoC) will now be held on July 14, 2026, via video conference. The meeting was originally scheduled for July 2, 2026, but was postponed. The filing itself provides no financial figures, resolution plan updates, or any metrics showing improvement or decline, offering only a procedural schedule.

• · CIRP was initiated on September 20, 2025.
• · Resolution Professional is registered with IBBI (Reg. No. IBBI/IPA-001/IP-P-02619/2021-2022/14043).
• · The meeting will be held via Video Conferencing.

13-07-2026

abrdn National Municipal Income Fund (VFL) is being delisted from NYSE American effective July 24, 2026, following its merger into Aberdeen Municipal Income Fund. Each VFL share was exchanged for 1.87521869 common shares of the acquirer, and trading was suspended on July 13, 2026.

• · The merger became effective on July 13, 2026.
• · Each VFL share was exchanged for 1.87521869 common shares of Aberdeen Municipal Income Fund, without interest, less any applicable fee and tax.
• · Trading was suspended on July 13, 2026.
• · Delisting is effective at the opening of business on July 24, 2026.

13-07-2026

Jai Mata Glass Ltd. (JMGL) received a mandatory open offer from Acquirers Mr. Ashwani Gulati, Ms. Kiran Gulati, and M/s Veerasha Trust to acquire up to 2,60,00,000 equity shares (26% of paid-up capital) at INR 1.85 per share, aggregating INR 4,81,00,000. The offer follows a Share Purchase Agreement (SPA) dated July 13, 2026, to acquire 44.57% of JMGL from the promoter group (Sellers) for INR 8,24,46,101, which triggered the open offer obligation under SEBI (SAST) Regulations. The Acquirers will gain control of JMGL, and the offer is not conditional on any minimum acceptance level.

• · The open offer price of INR 1.85 per share is the same as the SPA price.
• · Acquirers will hold 44.57% post-SPA, and the open offer could increase their stake to up to 70.57% if fully subscribed.
• · The Detailed Public Statement must be published by July 20, 2026.
• · The offer is not conditional on any minimum acceptance level and is not a competitive bid.
• · The Acquirers have made firm financial arrangements for the offer consideration.

13-07-2026

Black Pearl Equities LLC, through its subsidiaries, is launching a tender offer to acquire all outstanding shares of Selectis Health, Inc. at $5.75 per share in cash, with the offer expiring on August 10, 2026. The offer is subject to a minimum tender condition of 70% of outstanding shares, appraisal rights not exceeding 15%, and the Company maintaining at least $6.8M in unrestricted cash. The Company's Board has unanimously recommended the offer, and the transaction is expected to be followed by a merger that will take Selectis Health private.

• · The offer is being made pursuant to an Agreement and Plan of Merger dated June 22, 2026.
• · The Company's Board of Directors has unanimously recommended the offer and determined the Merger Agreement is fair to stockholders.
• · The Merger will be effected under Section 16-10a-1104 of the Utah Code without a stockholder meeting.
• · The Information Agent for the offer is Laurel Hill Advisory Group (GBCS).
• · The offer is subject to the Company demonstrating at least $6.8M in aggregate unrestricted cash and at least $2.88M in escrow cash.
• · The offer is also subject to the Company demonstrating good, valid and marketable fee simple title to all owned real property free of liens.

13-07-2026

Athena Technology Acquisition Corp. II deposited $271.48 into its trust account to extend the deadline to complete an initial business combination by one month, from July 14, 2026 to August 14, 2026. This is the second of up to nine potential monthly extensions available under the company's charter. The filing indicates the SPAC is still searching for a target and has not yet consummated a business combination.

• · The extension period runs from July 14, 2026 to August 14, 2026.
• · The company is an emerging growth company and has elected not to use the extended transition period for complying with new or revised financial accounting standards.

13-07-2026

Pluri Inc. received a Nasdaq notice on July 7, 2026, for non-compliance with the minimum $35 million market value of listed securities (MVLS) requirement under Listing Rule 5550(b)(2), and it also fails to meet alternative listing standards. The company has until January 4, 2027, to regain compliance, during which its shares will continue trading under the symbol 'PLUR'. Pluri is evaluating options but cannot assure it will regain compliance.

• · The company also fails to meet alternative listing standards: stockholders' equity of at least $2.5 million or net income of $500,000 from continuing operations in the most recently completed fiscal year, or in two of the three most recently completed fiscal years.
• · If compliance is not regained by January 4, 2027, Nasdaq will likely issue a delisting notification; the company may appeal to a Nasdaq Hearings Panel, which would stay any suspension or delisting pending the hearing process.

13-07-2026

Franklin Street Properties Corp. completed the sale of a property in Englewood, Colorado for $19.4 million on July 8, 2026. The transaction generated net proceeds of $17.5 million, of which $8.5 million was used to partially repay borrowings, resulting in a $1.1 million loss on debt extinguishment. Pro forma results show the disposition reduces rental revenue and expenses but does not materially change the company's net loss position, with pro forma net loss per share remaining at $(0.09) for Q1 2026 and widening to $(0.51) for FY 2025 (from $(0.43) historical).

• · The sale was completed on July 8, 2026, pursuant to a Purchase and Sale Agreement dated May 26, 2026, as amended on June 30, 2026.
• · No material relationships existed between the Seller and Buyer or their affiliates other than the Agreement.
• · Pro forma total assets decrease from $881.8M to $864.9M, and total liabilities decrease from $285.4M to $277.4M.
• · Pro forma rental revenue for FY 2025 declines by $4.2M to $103.0M, and for Q1 2026 declines by $1.1M to $25.2M.
• · Pro forma net loss for FY 2025 worsens from $(45.0M) historical to $(52.7M) pro forma, primarily due to the nonrecurring loss on sale of $7.9M.
• · The company remains a qualified REIT with no federal income tax provision on real estate operations.

13-07-2026

Onex Direct Lending BDC Fund filed a tender offer to repurchase up to 421,913 of its common shares (approximately 5% of outstanding shares as of June 30, 2026). The offer is an issuer tender offer under Rule 13e-4, and shares are not traded on an established secondary market. No officers, trustees, or affiliates intend to tender shares.

• · Shares are not traded on an established secondary trading market.
• · The tender offer is an issuer tender offer subject to Rule 13e-4.
• · No solicitation or recommendation fees are being paid to any person.
• · Audited financial statements for December 31, 2025 are incorporated by reference.

13-07-2026

The Trust for Professional Managers has filed a Form 25-NSE with the SEC to delist the CrossingBridge Ultra-Short Duration ETF from the Nasdaq Stock Market. The delisting is effective July 13, 2026, and is based on Section 17 CFR 240.12d2-2(a)(2), which typically applies when the issuer has failed to meet the exchange's continued listing standards or has otherwise ceased to be listed. No financial figures or performance metrics are provided in this filing.

• · The delisting is effective as of July 13, 2026.
• · The filing cites SEC rule 17 CFR 240.12d2-2(a)(2) as the basis for delisting.
• · The Trust for Professional Managers was formerly known as Zodiac Trust (name changed June 1, 2001).
• · The Nasdaq Stock Market LLC was formerly known as The Nasdaq Stock Market LLC (name changed February 24, 2006).

13-07-2026

Cantor Equity Partners II, Inc. (CEPT) filed Form 15 with the SEC on July 13, 2026, to terminate its registration under Section 12(g) of the Securities Exchange Act of 1934 following the consummation of a business combination with Securitize Inc. and Securitize Corp. As part of the deal, CEPT merged into a subsidiary of PubCo (Securitize Corp.), and the deregistration reflects that CEPT no longer has any holders of record of its Class A ordinary shares. The filing does not contain period-over-period financial comparisons, only the fact that CEPT became a wholly owned subsidiary and now has zero public shareholders.

• · The business combination was consummated effective July 1, 2026.
• · The Form 15 terminates CEPT's reporting obligations; PubCo (Securitize Corp.) continues to report under the Exchange Act.

13-07-2026

Genco Shipping & Trading Limited filed Amendment No. 21 to its Schedule 14D-9, responding to an unsolicited tender offer by Diana Shipping Inc. to purchase all Genco common stock for $24.80 per share in cash, without interest and less withholding taxes. The filing is purely procedural, adding an exhibit and certifying the information as of July 13, 2026.

• · This is Amendment No. 21 to the original Schedule 14D-9 filed May 15, 2026.
• · The unsolicited tender offer is by Diana Shipping Inc. and its subsidiary 4 Dragon Merger Sub Inc.
• · Exhibit (a)(67) is a statement issued by Genco on July 13, 2026.
• · No substantive changes to the prior statement are disclosed beyond the exhibit addition and certification.

13-07-2026

Tavia Acquisition Corp. (Nasdaq: TAVI) and Vita Inclinata Technologies, Inc. announced a non-binding Letter of Intent for a business combination that would take Vita public via a de-SPAC transaction. The proposed deal values Vita at a pre-money enterprise value of $450 million, contingent on Vita completing a pending strategic acquisition in the defense and industrials market. A definitive agreement is expected within 30 days, with a closing targeted for Q4 2026, though no assurances can be made that the transaction will be consummated.

• · The LOI is non-binding and no definitive agreement has been reached.
• · Tavia and Vita are engaged in initial non-binding investment indications from institutional investors and strategic partners; firm commitments will be announced with a definitive agreement.
• · The transaction is subject to completion of due diligence, negotiation of a definitive agreement, board and equity holder approvals, regulatory approvals, and other customary closing conditions.
• · No financial metrics (revenue, EBITDA, etc.) for Vita were disclosed in the filing.

13-07-2026

Selectis Health, Inc. (GBCS) is responding to a tender offer at $5.75 per share, which exceeds the independent valuation of $5.62 per share from Houlihan Valuation Advisors. The Board recommends the offer, citing the all-cash consideration and the company's ongoing operating losses ($2.7M in 2024, $1.6M in 2025, $1.3M in Q1 2026). However, the Board did not obtain a fairness opinion, and the valuation relied heavily on a net asset value approach, with no weight given to market or income approaches due to the company's lack of profitability and limited trading volume.

• · The Board did not obtain a fairness opinion from an investment bank, citing the Houlihan valuation, the negotiation history, and the cost-benefit analysis.
• · Houlihan's valuation gave 100% weight to the net asset value approach; no weight was given to market or income approaches due to the company's lack of profitability and limited trading volume.
• · The company sold two facilities in Georgia in May 2026, which was reflected in the valuation adjustments.
• · The Offer Price of $5.75 per share is $0.13 above Houlihan's $5.62 estimate, a 2.3% premium.
• · The company had a book value of only $258,344 as of the Valuation Date.
• · The debt commitment of up to $18M from Milrose Capital and SCG Experts Corp. is intended to fund the share purchase.

13-07-2026

Actelis Networks Inc. (ASNS) received official notice from Nasdaq on July 10, 2026, that its common stock will be delisted, following a suspension of trading on April 10, 2026. The delisting will become effective ten days after Nasdaq files a Form 25-NSE with the SEC. The company's stock currently trades on the OTCQB Venture Market under the symbol 'ASNS'.

• · Trading on Nasdaq was suspended on April 10, 2026, prior to the delisting notice.
• · The company's common stock now trades on the OTCQB Venture Market under the symbol 'ASNS'.
• · The delisting will become effective ten days after the Form 25-NSE is filed with the SEC.

13-07-2026

Launch One Acquisition Corp. shareholders approved an amendment to extend the company's business combination deadline from 24 months post-IPO to January 15, 2027, at an extraordinary general meeting held on July 10, 2026. The amendment provides additional time to complete an acquisition, reflecting ongoing efforts to identify a target. No financial figures or performance metrics were disclosed in this filing.

• · The extraordinary general meeting was held on July 10, 2026 at 10:00am Eastern Time at Ellenoff Grossman & Schole LLP, New York.
• · The amendment changes the Completion Window definition to end on January 15, 2027, or earlier/later as approved by directors or members.
• · The original deadline was 24 months after the IPO closing date.

13-07-2026

SC II Acquisition Corp. (SCIIU) announced on July 12, 2026, that it has terminated its non-binding letter of intent with an unnamed payments technology company, effective immediately, and will not pursue the proposed business combination. The termination leaves the SPAC without a target and with no further obligations under the LOI except for confidentiality provisions. This development increases uncertainty regarding the company's ability to complete an initial business combination within its available timeframe.

• · The LOI was entered into on March 31, 2026, and terminated on July 12, 2026.
• · The target was a payments technology company (not named).
• · The company retains confidentiality obligations under the LOI.
• · SC II Acquisition Corp. is a blank check company (SPAC) listed on Nasdaq under tickers SCIIU, SCII, and SCIIR.

13-07-2026

Evernorth Holdings Inc. filed a Form 425 communication on July 13, 2026, regarding its proposed business combination with Armada Acquisition Corp. II (a SPAC) and Pathfinder Digital Assets LLC, with Ripple Labs Inc. also party to the agreement. The transaction aims to create a publicly traded company focused on building an institutional XRP treasury and executing DeFi yield strategies. The filing is a procedural update and does not contain financial results or performance metrics, so no positive or negative financial trends are reported.

• · Business Combination Agreement was entered into on October 19, 2025.
• · A Registration Statement including a preliminary proxy statement/prospectus was filed on March 18, 2026, but is not yet effective.
• · The combined company's securities are expected to trade on Nasdaq.
• · The filing includes extensive risk factors related to digital asset volatility, regulatory changes, and the ability to complete the transaction.

13-07-2026

BNB Plus Corp. (BNBX) received a delisting notice from Nasdaq on July 10, 2026, after failing to maintain the $1.00 bid price requirement. The company's common stock will be suspended from trading on Nasdaq at the open on July 14, 2026, and is expected to move to the OTCQB Venture Market. The company plans to request a review by the Nasdaq Listing and Hearing Review Council, but there is no assurance of continued listing.

• · The company had previously received a bid price deficiency notice on March 20, 2026.
• · A hearing before the Nasdaq Hearings Panel was held on April 30, 2026.
• · The Panel granted an extension to June 11, 2026, to regain compliance.
• · On June 1, 2026, the company abandoned its reverse stock split plan and requested an additional 60-day extension to regain compliance organically.
• · The Panel declined the extension request.
• · The company intends to request a review by the Nasdaq Listing and Hearing Review Council, citing a recently closed financing and developments in its strategic review.
• · Trading on Nasdaq will be suspended at the open on July 14, 2026, regardless of the review request.
• · The company expects its common stock to trade on the OTCQB Venture Market under the same symbol 'BNBX' starting July 14, 2026.
• · The OTCQB market is described as significantly more limited than Nasdaq, likely resulting in reduced liquidity and potentially further depressing the stock price.
• · The transition is not expected to affect the company's business operations or SEC reporting requirements.

13-07-2026

Edgewise Therapeutics completed the sale of sevasemten and its muscular dystrophy business to Servier for $1.55 billion in upfront cash and up to $1.1 billion in milestones, for total potential consideration of up to $2.65 billion. The transaction strengthens Edgewise's balance sheet and sharpens its focus on its cardiovascular pipeline, including EDG-7500 for hypertrophic cardiomyopathy, EDG-15400 for HFpEF, and EDG-003. The company expects to initiate a Phase 3 trial for EDG-7500 in Q4 2026 and a Phase 2 trial for EDG-15400 in HFpEF, with upfront proceeds expected to fully fund EDG-7500 through potential approval.

• · The GRAND CANYON pivotal cohort in Becker is fully enrolled with 175 participants and powered at >98% to show a statistically significant difference vs placebo, with top-line data expected in Q4 2026.
• · Sevasemten has FDA Orphan Drug Designation for Becker and Duchenne, Rare Pediatric Disease Designation for Duchenne, Fast Track designations for both, and EMA Orphan Drug Designations for both.
• · In the MESA open-label extension study, participants maintained stable NSAA scores over more than three years, contrasting with expected functional decline from natural history data.
• · Sevasemten has had no discontinuations or dose reductions due to adverse events.
• · Approximately 12,000 individuals are affected by Becker muscular dystrophy in the U.S., EU-5, and Japan.

13-07-2026

Plum Acquisition Corp. III filed an 8-K on July 13, 2026, furnishing unaudited pro forma financial statements of Tactical Resources Corp. in connection with the previously announced business combination among Plum, Tactical, and Plum III Merger Corp. The pro forma balance sheet shows combined total assets of $39.2M as of April 30, 2026, including $30M in inventory from the crushed aggregate acquisition. The filing includes extensive forward-looking statements and risk factors, and the pro forma information is for illustrative purposes only.

• · The pro forma balance sheet includes a $30M inventory adjustment from the crushed aggregate inventory acquisition.
• · Cash held in trust account is reduced to zero after adjustments.
• · Promissory note – related party is eliminated through settlement entries.
• · The filing is dated July 13, 2026, but the earliest event reported is April 7, 2026.

13-07-2026

Esperion Therapeutics, Inc. (ESPR) filed a Form 25-NSE with the SEC on July 13, 2026, notifying the delisting of its common stock from the Nasdaq Stock Market. The delisting is effective as of the filing date and is being conducted under SEC Rule 17 CFR 240.12d2-2(a)(3), which typically applies to securities that have been withdrawn from listing or have failed to meet continued listing standards. This action marks a significant corporate event that will remove the company's shares from public trading on Nasdaq.

• · The delisting is effective immediately as of July 13, 2026.
• · The filing was made by Nasdaq Stock Market LLC, not by Esperion itself.
• · The delisting is under SEC Rule 240.12d2-2(a)(3), which applies to securities withdrawn from listing or failing to meet continued listing standards.
• · Esperion's SEC file number is 001-35986 and its CIK is 0001434868.
• · The company's business address is 3891 Ranchero Drive, Suite 150, Ann Arbor, MI 48108.

13-07-2026

Calisa Acquisition Corp (ALISR) filed an 8-K on July 13, 2026, disclosing that its merger target, GoodVision AI Inc., has joined the NVIDIA Connect program. This development is a positive milestone for GoodVision ahead of the proposed business combination, but the filing contains no financial figures or performance metrics, and the transaction remains subject to shareholder approval and regulatory conditions.

• · GoodVision AI Inc. joined the NVIDIA Connect program on July 8, 2026.
• · The business combination between Calisa Acquisition Corp and GoodVision is governed by a Business Combination Agreement (BCA).
• · The Company's securities trade on Nasdaq: Units (ALISU), Ordinary Shares (ALIS), Rights (ALISR).
• · The Company is an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.
• · A Registration Statement including a Proxy Statement/Prospectus has been filed with the SEC for the proposed transaction.

13-07-2026

CERO THERAPEUTICS HOLDINGS, INC. (CEROW) has been notified by Nasdaq that its securities will be delisted effective July 23, 2026, following a prolonged appeals process. The delisting stems from the company's failure to meet Nasdaq Listing Rule 5550(b)(1) regarding equity standards, with the initial staff determination dating back to August 2025. The company's securities have been suspended since October 31, 2025, and all appeals have been exhausted, including reviews by the Listing Qualifications Hearings Panel and the Nasdaq Listing and Hearing Review Council.

• · Initial delisting determination was made by Nasdaq Staff on August 28, 2025 for non-compliance with Listing Rule 5550(b)(1).
• · Company appealed the Staff determination on September 3, 2025, and a hearing was held on October 14, 2025.
• · The Panel decided to suspend the company on October 28, 2025, and the company appealed that decision on October 29, 2025.
• · The Nasdaq Listing and Hearing Review Council upheld the Panel's decision on January 29, 2025 (likely a typo for 2026).
• · A Final Action Letter was issued on February 6, 2026, and the Staff determination became final on December 15, 2025.
• · Company securities have been suspended since October 31, 2025.

13-07-2026

Japan Smaller Capitalization Fund Inc. (JOF) completed a tender offer to repurchase up to 10% of its outstanding shares. The Fund accepted 2,833,389 shares at $12.7792 per share (98% of NAV as of July 2, 2026). The offer was heavily oversubscribed with 22,006,123 shares tendered, resulting in a proration factor of approximately 12.88%.

• · Tender offer expired at 5:00 p.m. on July 1, 2026.
• · Payment for accepted shares occurred on or about July 10, 2026.
• · The offer was a 10% issuer tender offer under Rule 13e-4.
• · The Fund's net asset value per share as of July 2, 2026 was used to determine the purchase price.

13-07-2026

Nasdaq has determined to delist Graphjet Technology's Class A Ordinary Shares, effective July 23, 2026, after a prolonged compliance and appeal process. The company failed to meet multiple listing rules (5250(c)(1), 5450(a)(1), 5450(b)(2)(A), 5450(b)(2)(C)) and its shares have been suspended since November 13, 2025. Despite a temporary reprieve in September 2025, the Panel ultimately concluded the company did not articulate a reasonable plan to regain compliance, and all appeals were exhausted.

• · Shares were suspended on November 13, 2025.
• · The delisting became final on December 26, 2025, but was delayed due to the appeal process.
• · The company was placed on a Mandatory Panel Monitor after achieving temporary compliance in September 2025.
• · The Nasdaq Board of Directors did not call for review of the February 24, 2026 decision by the Listing and Hearing Review Council.

13-07-2026

Functional Brands Inc. (MEHA) received a final delisting notice from Nasdaq, effective July 23, 2026, after failing to meet Listing Rule 5550(a)(2) (minimum bid price or market value of publicly held shares). The company initially appealed the Staff determination on June 16, 2026, but formally withdrew its appeal on June 29, 2026, making the delisting final as of June 16, 2026. The stock was suspended on June 16, 2026, and will be removed from Nasdaq at the opening of trading on July 23, 2026.

• · The company was formerly known as HT Naturals Corp. until December 18, 2020.
• · The delisting is based on Listing Rule 5550(a)(2) and Rule 5810(c)(3)(A)(iii) (minimum bid price or market value of publicly held shares).
• · The company withdrew its appeal on June 29, 2026, and the delisting became final on June 16, 2026.
• · The stock was suspended on June 16, 2026.

13-07-2026

Bitcoin Depot Inc. (BTMWW) received a final delisting notice from Nasdaq, effective July 23, 2026, after Nasdaq Staff determined the company no longer qualified for listing under Listing Rules 5101, 5110(b), and IM-5101-1. The company did not appeal the staff's delisting determination, which became final on May 26, 2026, and its securities have been suspended since that date.

• · The delisting is effective from the opening of trading on July 23, 2026.
• · Nasdaq Staff determination was based on Listing Rules 5101, 5110(b), and IM-5101-1.
• · The company was notified of the staff determination on May 18, 2026.
• · The company did not appeal the Staff's Delist Determination Letter.
• · Company securities were suspended on May 26, 2026, the same date the delisting determination became final.

13-07-2026

Inception Growth Acquisition Ltd deposited $12,203.33 into its trust account to extend the deadline for completing a business combination by one month, from July 13, 2026 to August 13, 2026. The extension provides additional time to finalize a merger or acquisition, but the company has not yet announced a target or definitive agreement.

• · The extension is from July 13, 2026 to August 13, 2026 (one month).
• · The company's securities trade on OTC Markets Group, Inc. under symbols IGTAU (units), IGTA (common stock), IGTAW (warrants), and IGTAR (rights).
• · The company is a blank check company (SPAC) incorporated in Delaware.

13-07-2026

REE Automotive Ltd. received a final delisting determination from Nasdaq on July 10, 2026, after failing to meet Listing Rule 5550(a)(2) (minimum bid price requirement). The company did not appeal the Staff's delisting determination, and its Class A Ordinary Shares were suspended on July 7, 2026. The delisting becomes effective at the opening of trading on July 23, 2026.

• · Nasdaq Staff determination was based on Listing Rule 5550(a)(2) (minimum bid price).
• · Company was notified of the Staff determination on June 30, 2026.
• · Company did not appeal the Staff's delisting determination.
• · Shares were suspended on July 7, 2026.
• · Delisting effective at the opening of the trading session on July 23, 2026.